Filling the need for trusted information on national health issues…

Private Sector Involvement

  • Your Selections:

Refine Results

date

Tags

IBT Examines Strategies Aimed At Promoting Antibiotic Drug Development

International Business Times: Antibiotic Resistance: Why Aren’t Drug Companies Developing New Medicines To Stop Superbugs? “…[A]s many as 10 million people a year could die from antibiotic-resistant bacteria worldwide by 2050 if new treatments are not discovered, according to a recent report from the Review on Antimicrobial Resistance. … Despite…

Experimental Ebola Drug Shows Promise In Treating Early Infection, Study Shows

Agence France-Presse: Limited promise in early results from Ebola drug trial “Early results from an Ebola trial using the experimental drug Avigan (favipiravir) showed it was somewhat effective at saving lives if given early in the illness, but not later…” (2/23). Reuters: Ebola drug in Guinea helps some, stirs debate…

After 5-Year Tenure, USAID Administrator Rajiv Shah Parts Agency With 5 Lessons

U.S. State Department’s “DipNote”: Farewell: Reflections on Five Years of U.S. Development Assistance USAID Administrator Rajiv Shah reflects on his five-year tenure at the agency with five parting lessons for carrying the U.S. development agenda forward. “…We will have the opportunity to come together and seize the moment, by elevating…

Vaccines Represent ‘Vital Early Weapon’ For Next Ebola Outbreak

The Lancet Global Health: Ebola vaccines: an uncertain future? Zoë Mullan, editor of The Lancet Global Health “…The rapid roll-out of these [Ebola vaccine] trials has been tremendously impressive. … Vaccines are not a magic bullet. Nothing can replace the basic tenets of public health epidemiology and community mobilization. But…

GHIT Joins Gates Foundation In Grand Challenge Against NTDs, Pledges Initial $4M For Drug, Vaccine Development

SciDev.Net: Japan joins Gates’s Grand Challenge on tropical diseases “The Gates Foundation and Japan [on Thursday] launched a Grand Challenge to tackle neglected diseases, with an initial funding pledge of U.S. $4 million supplied jointly with Japanese companies. … The Tokyo-based Global Health Innovative Technology (GHIT) Fund, of which the [Gates…

UCSF Releases Paper On Private Health Sector’s Role In Malaria Surveillance

UCSF Global Health Sciences: Background Paper: The Private Sector’s Role in Malaria Surveillance UCSF Global Health Sciences Global Health Group published a background paper “synthesizing current research and expert knowledge on the current state of the private health sector’s role in malaria surveillance. [The paper discusses] key challenges and how…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.